Gilead Sciences Inc (NASDAQ:GILD)

67.38
Delayed Data
As of May 25
 -0.15 / -0.22%
Today’s Change
63.76
Today|||52-Week Range
89.54
-5.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line12.1B18.1B13.5B4.6B
 
 
 
 
 
Depreciation1.1B1.1B1.2B1.3B
 
 
 
 
 
Total Other Cash Flow463.0M355.0M780.0M942.0M
 
 
 
 
 
Funds From Operations13.3B19.2B15.3B6.8B
 
 
 
 
 
Funds From/For Other Operating Expenses518.0M-1.2B-1.4B-5.1B
 
 
 
 
 
Net Cash Flow - Operating Activities12.8B20.3B16.7B11.9B
 
 
 
 
 
 
InvestingIncrease In Investments-2.1B-17.2B-26.0B-23.3B
 
 
 
 
 
Decrease In Investments859.0M5.5B14.7B18.3B
 
 
 
 
 
Capital Expenditures-557.0M-747.0M-748.0M-590.0M
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-10.4B
 
 
Net Cash Flow Investing-1.8B-12.5B-12.0B-16.1B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings10.5B10.7B6.2B9.0B
 
 
 
 
 
Long Term Debt Reduction-4.8B-997.0M-2.0B-1.8B
 
 
 
 
 
Net Proceeds Stock Sale331.0M319.0M208.0M234.0M
 
 
 
 
 
Common Preferred Redeemed-5.3B-10.0B-11.0B-954.0M
 
 
 
 
 
Common Dividends0.00-1.9B-2.5B-2.7B
 
 
 
 
Cash Dividends Paid - Total0.00-1.9B-2.5B-2.7B
 
 
 
 
Other Sources - Financing517.0M773.0M194.0M--
 
 
 
 
Other Uses - Financing4.2B3.9B561.0M330.0M
 
 
 
 
 
Net Cash Flow - Financing-3.0B-5.0B-9.3B3.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-56.0M-67.0M41.0M137.0M
 
 
 
 
 
 
Net Change In Cash8.0B2.9B-4.7B-778.0M